SB 690 Drug Price Transparency: (NOW INCLUDED IN HB 1280)

We must be able to know what is going on with prices, to responsibly control drug prices to hold lawmakers, insurance companies and pharmaceutical companies accountable for their actions. This bill establishes a drug affordability board to get more information about proposed prices hikes and to inform cost control strategies. It also requires drug manufacturers to report price increases over 20 percent.

New Futures Supports SB 690: Click here to read.